Key clinical point: Infectious disease consultation should be an integral for patients with candida bloodstream infections.
Major finding: The 90-day mortality was lower with ID consultation than in patients who did not receive consultation (29% vs. 51%; P less than .0001)
Study details: The retrospective, single-center cohort study assessed 1,691 patients with candida bloodstream infection from 2002 to 2015.
Disclosures: Astellas Global Development Pharma and the Agency for Healthcare Research and Quality funded the study. Several authors reported funding from Astellas and from other pharmaceutical companies.
Mejia-Chew C et al. Lancet Infect Dis 2019;19(12):1336–44.